Disease · MONDO_0005929
Comparisons in its trials16
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 16 of 16
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| SAGE-217 50 mg vs Placebo: deaths from any cause | 0 of 98 | 0 of 98 | 196 | NCT04442503 | Trial comparisons |
| SAGE-217 50 mg vs Placebo: serious adverse events | 2 of 98 | 0 of 98 | 196 | NCT04442503 | Trial comparisons |
| SAGE-547 90 μg/kg/h vs Placebo: deaths from any cause | 0 of 51 | 0 of 53 | 104 | NCT02942017 | Trial comparisons |
| SAGE-547 90 μg/kg/h vs Placebo: serious adverse events | 1 of 51 | 0 of 53 | 104 | NCT02942017 | Trial comparisons |
| Combined Spinal Epidural (CSE) vs Epidural: deaths from any cause | 0 of 31 | 0 of 30 | 61 | NCT03022526 | Trial comparisons |
| Combined Spinal Epidural (CSE) vs Epidural: serious adverse events | 0 of 31 | 0 of 30 | 61 | NCT03022526 | Trial comparisons |
| Combined Spinal Epidural (CSE) vs Epidural: Number of Participants Currently Breastfeeding at 2 Days Postpartum (Yes/No) | 22 of 25 | 18 of 28 | 53 | NCT03022526 | Trial comparisons |
| Combined Spinal Epidural (CSE) vs Epidural: Number of Participants Currently Breastfeeding at 6 Weeks Postpartum (Yes/No) | 15 of 20 | 12 of 24 | 44 | NCT03022526 | Trial comparisons |
| Combined Spinal Epidural (CSE) vs Epidural: Number of Participants Currently Breastfeeding at 3 Months Postpartum (Yes/No) | 9 of 15 | 8 of 23 | 38 | NCT03022526 | Trial comparisons |
| SAGE-547 vs Placebo: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | 4 of 10 | 8 of 11 | 21 | NCT02614547 | Trial comparisons |
| SAGE-547 vs Placebo: deaths from any cause | 0 of 10 | 0 of 11 | 21 | NCT02614547 | Trial comparisons |
| SAGE-547 vs Placebo: serious adverse events | 0 of 10 | 0 of 11 | 21 | NCT02614547 | Trial comparisons |
| Estradiol vs Placebo: deaths from any cause | 0 of 6 | 0 of 6 | 12 | NCT00059228 | Trial comparisons |
| Estradiol vs Placebo: serious adverse events | 0 of 6 | 0 of 6 | 12 | NCT00059228 | Trial comparisons |
| Ketamine 0.5 mg/kg vs Ketamine 0.2 mg/kg: deaths from any cause | 0 of 1 | 0 of 1 | 2 | NCT04011592 | Trial comparisons |
| Ketamine 0.5 mg/kg vs Ketamine 0.2 mg/kg: serious adverse events | 0 of 1 | 0 of 1 | 2 | NCT04011592 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0005929/comparisons